Author details

Full Name

Jinu Abraham

Affiliation

Oregon Health & Science University

ORCID

Career Start Year

2010

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33853867	Interleukin-4 Receptor Inhibition Targeting Metastasis Independent of Macrophages.	Mol Cancer Ther	2021
33853867	Interleukin-4 Receptor Inhibition Targeting Metastasis Independent of Macrophages.	Mol Cancer Ther	2021
32733475	Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.	Front Immunol	2020
32733475	Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.	Front Immunol	2020
30755509	Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1Î² Protein during Virion-Mediated Activation of the AIM2 Inflammasome.	mBio	2019
30755509	Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1Î² Protein during Virion-Mediated Activation of the AIM2 Inflammasome.	mBio	2019
31208434	Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.	BMC Cancer	2019
31113472	Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.	Skelet Muscle	2019
31208434	Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.	BMC Cancer	2019
31113472	Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.	Skelet Muscle	2019
29263267	Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.	J Virol	2018
30459282	The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.	Sci Signal	2018
29263267	Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.	J Virol	2018
30459282	The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.	Sci Signal	2018
28465426	A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.	mBio	2017
28465426	A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.	mBio	2017
27255663	IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.	Sci Rep	2016
27255663	IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.	Sci Rep	2016
25939062	Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.	Nat Med	2015
25883905	The case for primary salivary rhabdomyosarcoma.	Front Oncol	2015
25939062	Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.	Nat Med	2015
26646986	Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.	PLoS Pathog	2015
26151328	Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.	Nat Med	2015
26646986	Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.	PLoS Pathog	2015
26151328	Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.	Nat Med	2015
25883905	The case for primary salivary rhabdomyosarcoma.	Front Oncol	2015
24733895	PDGFRÎ² reverses EphB4 signaling in alveolar rhabdomyosarcoma.	Proc Natl Acad Sci U S A	2014
25030697	Lineage of origin in rhabdomyosarcoma informs pharmacological response.	Genes Dev	2014
24733895	PDGFRÎ² reverses EphB4 signaling in alveolar rhabdomyosarcoma.	Proc Natl Acad Sci U S A	2014
25030697	Lineage of origin in rhabdomyosarcoma informs pharmacological response.	Genes Dev	2014
23526721	A case study of personalized therapy for osteosarcoma.	Pediatr Blood Cancer	2013
23897781	IL-4 receptor blockade abrogates satellite cell: rhabdomyosarcoma fusion and prevents tumor establishment.	Stem Cells	2013
23928059	Dynamic and nuclear expression of PDGFRÎ± and IGF-1R in alveolar Rhabdomyosarcoma.	Mol Cancer Res	2013
24274149	Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma.	Skelet Muscle	2013
23526721	A case study of personalized therapy for osteosarcoma.	Pediatr Blood Cancer	2013
24274149	Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma.	Skelet Muscle	2013
23897781	IL-4 receptor blockade abrogates satellite cell: rhabdomyosarcoma fusion and prevents tumor establishment.	Stem Cells	2013
23928059	Dynamic and nuclear expression of PDGFRÎ± and IGF-1R in alveolar Rhabdomyosarcoma.	Mol Cancer Res	2013
22146535	Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model.	J Pediatr Hematol Oncol	2012
22960170	An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma.	Biochem Biophys Res Commun	2012
22146535	Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model.	J Pediatr Hematol Oncol	2012
21989738	CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.	Int J Cancer	2012
22238194	18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.	Pediatr Blood Cancer	2012
22960170	An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma.	Biochem Biophys Res Commun	2012
22238194	18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.	Pediatr Blood Cancer	2012
21989738	CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.	Int J Cancer	2012
21447712	Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma.	Mol Cancer Ther	2011
21316601	Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma.	Cancer Cell	2011
21536546	IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma.	Clin Cancer Res	2011
21447712	Evasion mechanisms to Igf1r inhibition in rhabdomyosarcoma.	Mol Cancer Ther	2011

1 - 50 of 58

Patricia Jaaks

Wellcome Sanger Institute

Career Start Year 2015

Number of shared co-authors 1

Elizabeth Stewart

St Jude Children's Research Hospital

Career Start Year 2006

Number of shared co-authors 5

Didier Surdez

Balgrist University Hospital, University of Zurich (UZH)

Career Start Year 2005

Number of shared co-authors 3

Joseph A Ludwig

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 1

Arnulfo Mendoza

National Cancer Institute, National Institutes of Health

Career Start Year 2004

Number of shared co-authors 5

Stacey J Adam

Foundation for the National Institutes of Health

Career Start Year 2004

Number of shared co-authors 0

Xiaohu Zhang

National Center for Advancing Translational Sciences

Career Start Year 2003

Number of shared co-authors 3

Donghui Cheng

University of California los angeles

Career Start Year 2003

Number of shared co-authors 0

Zhigang Kang

Center for Cancer Research, National Cancer Institute

Career Start Year 2002

Number of shared co-authors 3

Daniel Martinez

Perelman School of Medicine at the University of Pennsylvania

Career Start Year 2002

Number of shared co-authors 3

Phillip M Clair

Huntsman Cancer Institute, The University of Utah

Career Start Year 2001

Number of shared co-authors 2

Noah Federman

University of California los angeles

Career Start Year 2001

Number of shared co-authors 0

Qingxia Wei

Princess Margaret Cancer Centre, University Health Network and University of Toronto

Career Start Year 2000

Number of shared co-authors 0

Oscar M Tirado

Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC

Career Start Year 2000

Number of shared co-authors 2

Christopher D Willey

University of Alabama at Birmingham

Career Start Year 2000

Number of shared co-authors 2

Angela C Hirbe

Washington University School of Medicine and Siteman Cancer Center

Career Start Year 1999

Number of shared co-authors 0

Cristina E Tognon

Knight Cancer Institute, Oregon Health & Science University

Career Start Year 1993

Number of shared co-authors 5

Enrique de Alava

Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.

Career Start Year 1992

Number of shared co-authors 3

Aykut Uren

Georgetown University Medical Center

Career Start Year 1991

Number of shared co-authors 4

John Easton

St Jude Children's Research Hospital

Career Start Year 1991

Number of shared co-authors 3

E Alejandro Sweet-Cordero

University of California San Francisco

Career Start Year 1989

Number of shared co-authors 3

Glenn M Marshall

Children's Cancer Institute, Lowy Cancer Research Centre

Career Start Year 1989

Number of shared co-authors 2

Poul H Sorensen

British Columbia Cancer Research Centre

Career Start Year 1989

Number of shared co-authors 10

Choh Yeung

Center for Cancer Research, National Cancer Institute

Career Start Year 1987

Number of shared co-authors 4

Jeffrey A Toretsky

Georgetown University Medical Center, Georgetown University

Career Start Year 1986

Number of shared co-authors 4

David M Loeb

Children's Hospital at Montefiore.

Career Start Year 1986

Number of shared co-authors 8

Beat W Sch??fer

Department of Oncology and Children's Research Center, University Children's Hospital

Career Start Year 1985

Number of shared co-authors 9

William A Weiss

University of California san francisco

Career Start Year 1985

Number of shared co-authors 4

Lee J Helman

Osteosarcoma Institute

Career Start Year 1977

Number of shared co-authors 13

Timothy J Triche

Center for Epigenetics, Van Andel Research Institute

Career Start Year 1971

Number of shared co-authors 7

row(s) 1 - 30 of 30

Charles Keller

Children's Cancer Therapy Development Institute

Co-authored papers 24

Joel E Michalek

University of Texas Health Science Center

Co-authored papers 14

Brian P Rubin

Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic

Co-authored papers 11

Atiya Mansoor

Oregon Health & Science University

Co-authored papers 9

Matthew N Svalina

University of Colorado Anschutz Medical Campus

Co-authored papers 7

Suresh I Prajapati

Co-authored papers 7

Noah E Berlow

Children's Cancer Therapy Development Institute

Co-authored papers 7

Ranadip Pal

Texas Tech University

Co-authored papers 7

Lee Ann Zarzabal

University of Texas Health Science Center

Co-authored papers 6

Koichi Nishijo

Institute for Frontier Medical Sciences, Kyoto University

Co-authored papers 5

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 5

Victor R DeFilippis

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 5

Martin Goros

University of Texas Health San Antonio

Co-authored papers 5

Daniel N Streblow

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Co-authored papers 4

Jeffrey W Tyner

Oregon Health & Science University School of Medicine

Co-authored papers 4

Amanda T McCleish

Co-authored papers 4

Elaine Huang

Oregon Health and Science University, 3710 SW US Veterans Hospital Rd

Co-authored papers 4

Brian J Druker

Oregon Health & Science University

Co-authored papers 3

Douglas S Hawkins

Co-authored papers 3

Yidong Chen

Zhujiang Hospital, Southern Medical University

Co-authored papers 3

Susan R Davis

Co-authored papers 3

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 3

Bing-Hung Chen

Kaohsiung Medical University

Co-authored papers 3

Ken Kikuchi

Kyoto Prefectural University of Medicine

Co-authored papers 3

Lin Qi

Xiangya Hospital of Central South University

Co-authored papers 2

Xiao-Nan Li

Northwestern University